Elanco Animal Health Inc at JPMorgan Healthcare Conference Transcript
Good morning, everybody. I'm Chris Schott at JPMorgan, and it's my pleasure to be introducing Elanco this morning. From the company, we have Jeff Simmons, the company's President and CEO, and we're going to have the company's CFO, Todd Young, joining for Q&A. Before I turn it over to Jeff, I just want to remind people have a question, you can ask that through the portal, and I'll work those into the Q&A post the presentation. So with that, Jeff, Happy New Year. Thanks for joining us, and we turn over to you.
Well, good morning, and thanks, Chris. Thanks for JPMorgan and covering the animal health space and have been a long history of doing that. So thank you, and we appreciate the opportunity to engage with investors today. As always, look at Slide 2 for our disclaimers on our forward-looking statements and what I'm going to do here is just to cover really here on Slide 3, the
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |